Kim Rosalie Kampen

This paper shows that sertraline and carfilzomib work together to kill T-cell cancers by disrupting metabolism and changing the immune environment.

This study shows that deficiencies in Fanconi Anemia or homologous recombination pathways enhance the antitumor effects of CP-506, a hypoxia-activated prodrug, through synthetic lethality mechanisms.

This study identifies compensatory pathway activation as a mechanism of resistance to single-agent small-molecule inhibitors in glioblastoma and shows that combination therapy can overcome this resistance.